Genpact insider files Form 144 to sell 55,000 shares via Morgan Stanley

Rhea-AI Filing Summary

Genpact Limited (G) officer or insider filed a Form 144 to sell 55,000 common shares through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $2,384,883.50 and an approximate sale date of 09/11/2025. The filing reports 174,270,076 shares outstanding for the issuer, implying the notice covers a small fraction of outstanding stock.

The securities to be sold were acquired partly by a stock option exercise on 09/11/2025 (40,000 shares, paid in cash) and partly as performance shares granted 01/10/2022 (15,000 shares). The filer states there were no shares sold in the past three months and attests they have no undisclosed material adverse information.

Insights

Securities Analyst

TL;DR Insider plans to sell 55,000 shares (~0.03% of outstanding), largely from a same-day option exercise and vested performance shares.

The filing is routine: the sale is executed through a major broker and the holding represents a very small portion of the company's outstanding equity, suggesting limited direct market impact. The combination of a same-day option exercise and vested performance shares is consistent with ordinary insider liquidity events and compensation realization. Absence of sales in the prior three months and the standard attestation about undisclosed material information further indicate this is a compliance-driven disclosure rather than a signal of material corporate change.

Corporate Governance Expert

TL;DR Disclosure aligns with Rule 144 requirements; timing and mix of grant types indicate compensation-related sale rather than extraordinary event.

The transaction details—40,000 shares from a stock option exercise paid in cash and 15,000 performance shares—reflect routine monetization of vested compensation. Filing through Morgan Stanley Smith Barney LLC and the explicit representation regarding material information are standard governance hygiene. There is no indication of governance concerns, unexpected departures, or clustered insider selling in the recent three-month window based on this notice alone.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	55000	2384883.50	174270076	09/11/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/11/2025	Stock Option Exercise	Issuer			40000	09/11/2025	Cash
Common	01/10/2022	Performance Shares	Issuer			15000	01/10/2022	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares does the Genpact (G) Form 144 notice cover?

The notice covers 55,000 common shares to be sold on the NYSE through Morgan Stanley Smith Barney LLC.

What is the aggregate market value of the shares in the Genpact Form 144?

The aggregate market value reported is $2,384,883.50.

When is the approximate sale date listed in the Form 144 for G?

The approximate date of sale listed is 09/11/2025.

How were the 55,000 shares acquired according to the filing?

The filing shows 40,000 acquired via a stock option exercise on 09/11/2025 (cash) and 15,000 as performance shares granted 01/10/2022.

Does the Form 144 disclose any sales by the filer in the prior three months?

No. The filing states 'Nothing to Report' for securities sold during the past three months.